Table 1.
The relationship between PGK1 expression and clinicopathological characteristics in TCGA LUAD samples.
| Characteristic | Low Expression of PGK1 | High Expression of PGK1 | FDR |
|---|---|---|---|
| n | 267 | 268 | |
| T stage, n (%) | 0.0345 | ||
| T1 | 103 (19.4%) | 72 (13.5%) | |
| T2 | 130 (24.4%) | 159 (29.9%) | |
| T3 | 25 (4.7%) | 24 (4.5%) | |
| T4 | 7 (1.3%) | 12 (2.3%) | |
| N stage, n (%) | 0.0456 | ||
| N0 | 186 (35.8%) | 162 (31.2%) | |
| N1 | 39 (7.5%) | 56 (10.8%) | |
| N2 | 32 (6.2%) | 42 (8.1%) | |
| N3 | 0 (0%) | 2 (0.4%) | |
| M stage, n (%) | 0.0345 | ||
| M0 | 179 (46.4%) | 182 (47.2%) | |
| M1 | 6 (1.6%) | 19 (4.9%) | |
| Pathologic stage, n (%) | 0.0345 | ||
| Stage I | 161 (30.6%) | 133 (25.2%) | |
| Stage II | 55 (10.4%) | 68 (12.9%) | |
| Stage III | 39 (7.4%) | 45 (8.5%) | |
| Stage IV | 7 (1.3%) | 19 (3.6%) | |
| Number of packs per year smoked, n (%) | 0.0345 | ||
| <40 | 110 (29.8%) | 78 (21.1%) | |
| ≥40 | 79 (21.4%) | 102 (27.6%) | |
| Smoker, n (%) | 0.3270 | ||
| No | 33 (6.3%) | 42 (8.1%) | |
| Yes | 227 (43.6%) | 219 (42%) |